-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Upgrades Progyny to Buy, Raises Price Target to $30

Benzinga·05/19/2026 13:37:51
Listen to the news
Canaccord Genuity analyst Richard Close upgrades Progyny (NASDAQ:PGNY) from Hold to Buy and raises the price target from $19 to $30.